High glucose induced VEGF expression via PKC and ERK in glomerular podocytes

被引:136
作者
Hoshi, S
Nomoto, K
Kuromitsu, J
Tomari, S
Nagata, M [1 ]
机构
[1] Univ Tsukuba, Inst Clin Med, Dept Pathol, Tsukuba, Ibaraki 3058575, Japan
[2] Univ Tsukuba, Inst Basic Med Sci, Dept Pathol, Tsukuba, Ibaraki 3058575, Japan
[3] Eisai & Co Ltd, Tsukuba Res Labs, Ibaraki, Japan
关键词
diabetic nephropathy; podocyte; vascular endothelial growth factor; protein kinase C; extracellular signal-regulated kinase; activator protein-1; high glucose;
D O I
10.1006/bbrc.2001.6138
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Podocytes are the major site of vascular endothelial growth factor (VEGF) production in the kidney, and up-regulation of VEGF plays a critical role in the progression of diabetic nephropathy. Using a differentiated mouse podocyte cell line, we investigated the roles of protein kinase C (PKC) and extracellular signal-regulated kinase (ERK) on the expression of VEGF under high glucose conditions. High glucose induced up-regulation of VEGF mRNA and protein expression in podocytes via activation of PKC (PKC-alpha and -betaII isoforms) and ERK. High glucose stimulated [H-3]leucine incorporation in the podocytes. High glucose and the PKC stimulator, phorbol 12-myristate 13-acetate (PMA) induced activator protein-1 (AP-1)-dependent transcriptional activity and expression of VEGF. In addition, these phenomena were blocked by specific inhibitors of PKC (GF10902X) and ERK kinase (PD98059). These observations suggested that high glucose-induced VEGF expression in podocytes was largely mediated through PKC and ERK pathways that may be involved in diabetic nephropathy. (C) 2002 Elsevier Science.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 42 条
[1]   Role of vascular endothelial growth factor in diabetic vascular complications [J].
Aiello, LP ;
Wong, JS .
KIDNEY INTERNATIONAL, 2000, 58 :S113-S119
[2]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[3]   VASCULAR-PERMEABILITY FACTOR MESSENGER-RNA AND PROTEIN EXPRESSION IN HUMAN KIDNEY [J].
BROWN, LF ;
BERSE, B ;
TOGNAZZI, K ;
MANSEAU, EJ ;
VANDEWATER, L ;
SENGER, DR ;
DVORAK, HF ;
ROSEN, S .
KIDNEY INTERNATIONAL, 1992, 42 (06) :1457-1461
[4]   Role of vascular endothelial growth factor in diabetic nephropathy [J].
Cha, DR ;
Kim, NH ;
Yoon, JW ;
Jo, SK ;
Cho, WC ;
Kim, HK ;
Won, NH .
KIDNEY INTERNATIONAL, 2000, 58 :S104-S112
[5]   Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes [J].
Coimbra, TM ;
Janssen, U ;
Gröne, HJ ;
Ostendorf, T ;
Kunter, U ;
Schmidt, H ;
Brabant, G ;
Floege, J .
KIDNEY INTERNATIONAL, 2000, 57 (01) :167-182
[6]   Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes [J].
Cooper, ME ;
Vranes, D ;
Youssef, S ;
Stacker, SA ;
Cox, AJ ;
Rizkalla, B ;
Casley, DJ ;
Bach, LA ;
Kelly, DJ ;
Gilbert, RE .
DIABETES, 1999, 48 (11) :2229-2239
[7]   INCREASE IN DIACYLGLYCEROL MASS IN ISOLATED GLOMERULI BY GLUCOSE FROM DENOVO SYNTHESIS OF GLYCEROLIPIDS [J].
CRAVEN, PA ;
DAVIDSON, CM ;
DERUBERTIS, FR .
DIABETES, 1990, 39 (06) :667-674
[8]   THE ROLE OF THE GLOMERULAR EPITHELIAL-CELL IN THE MAINTENANCE OF THE GLOMERULAR-FILTRATION BARRIER [J].
DANIELS, BS .
AMERICAN JOURNAL OF NEPHROLOGY, 1993, 13 (05) :318-323
[9]  
De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993
[10]   Molecular biology of diabetic glomerulosclerosis [J].
Del Prete, D ;
Anglani, F ;
Ceol, M ;
D'Angelo, A ;
Forino, M ;
Vianello, D ;
Baggio, B ;
Gambaro, G .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 :20-25